Global Liposomes Drug Delivery Market Study 2016-2026, by Segment (Liposomal doxorubicin, Liposomal Amphoteracin B, … …), by Market (Fungal Infection Therapy, Cancer Therapy ( Tumor therapy), … …), by Company (Johnson & Johnson, Gilead Sciences, … …)

Get in-depth COVID-19 impact and recovery analysis on the Global Liposomes Drug Delivery Market

Flash Discount
15% Single User
20% Multi User
25% Corporate
30% Enterprise
  • Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

    The global Liposomes Drug Delivery market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.


    Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

    Liposomal doxorubicin

    Liposomal Amphoteracin B

    Liposomal Paclitaxel

    Others

    Demand Coverage (Market Size & Forecast, Consumer Distribution):

    Fungal Infection Therapy

    Cancer Therapy ( Tumor therapy)

    Others


    Company Coverage (Sales data, Main Products & Services etc.):

    Johnson & Johnson

    Gilead Sciences

    Luye Pharma

    Sun Pharmaceutical

    Pacira

    Fudan-Zhangjiang

    Sigma-Tau Group

    Teva Pharmaceutical

    CSPC

    Novartis

    Crucell

    Celsion Corporation

    Kingond Pharm

    Shanghai New Asia

    Spectrum Pharmaceuticals

    Major Region Market

    North America

    Europe

    Asia-Pacific

    South America

    Middle East & Africa

     

  • With tables and figures helping analyze worldwide Global Liposomes Drug Delivery market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Table of Content

    1 Industry Overview

    1.1 Liposomes Drug Delivery Industry

    1.1.1 Overview
    1.1.2 Products of Major Companies

    1.2 Market Segment

    1.2.1 Industry Chain
    1.2.2 Consumer Distribution

    1.3 Price & Cost Overview


    2 Liposomes Drug Delivery Market by Type

    2.1 By Type

    2.1.1 Liposomal doxorubicin
    2.1.2 Liposomal Amphoteracin B
    2.1.3 Liposomal Paclitaxel
    2.1.4 Others

    2.2 Market Size by Type

    2.3 Market Forecast by Type


    3 Global Market Demand

    3.1 Segment Overview

    3.1.1 Fungal Infection Therapy
    3.1.2 Cancer Therapy ( Tumor therapy)
    3.1.3 Others

    3.2 Market Size by Demand

    3.3 Market Forecast by Demand


    4 Major Region Market

    4.1 Global Market Overview

    4.1.1 Market Size & Growth
    4.1.2 Market Forecast

    4.2 Major Region

    4.2.1 Market Size & Growth
    4.2.2 Market Forecast

    5 Major Companies List

    5.1 Johnson & Johnson (Company Profile, Sales Data etc.)

    5.2 Gilead Sciences (Company Profile, Sales Data etc.)

    5.3 Luye Pharma (Company Profile, Sales Data etc.)

    5.4 Sun Pharmaceutical (Company Profile, Sales Data etc.)

    5.5 Pacira (Company Profile, Sales Data etc.)

    5.6 Fudan-Zhangjiang (Company Profile, Sales Data etc.)

    5.7 Sigma-Tau Group (Company Profile, Sales Data etc.)
    5.8 Teva Pharmaceutical (Company Profile, Sales Data etc.)
    5.9 CSPC (Company Profile, Sales Data etc.)
    5.10 Novartis (Company Profile, Sales Data etc.)
    5.11 Crucell (Company Profile, Sales Data etc.)
    5.12 Celsion Corporation (Company Profile, Sales Data etc.)
    5.13 Kingond Pharm (Company Profile, Sales Data etc.)
    5.14 Shanghai New Asia (Company Profile, Sales Data etc.)
    5.15 Spectrum Pharmaceuticals (Company Profile, Sales Data etc.)

    6 Conclusion

     

  • The Global Liposomes Drug Delivery Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
    • Johnson & Johnson
    • Gilead Sciences
    • Luye Pharma
    • Sun Pharmaceutical
    • Pacira
    • Fudan-Zhangjiang
    • Sigma-Tau Group
    • Teva Pharmaceutical
    • CSPC
    • Novartis
    • Crucell
    • Celsion Corporation
    • Kingond Pharm
    • Shanghai New Asia
    • Spectrum Pharmaceuticals
    By Regions:
    • North America
    • Europe
    • Asia-Pacific
    • South America
    • Middle East & Africa
    By Type:
    • Liposomal doxorubicin
    • Liposomal Amphoteracin B
    • Liposomal Paclitaxel
    • Others
    By Application:
    • Fungal Infection Therapy
    • Cancer Therapy ( Tumor therapy)
    • Others
Licensing options
1800
USD

Need assistance ?

Research objectives

Where will all these developments take the industry in the long

To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

What are the future opportunities in the market?

To understand the structure of Market by identifying its various subsegments.

What are the major driving forces expected to impact the development of the market market across different regions?

To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

To project the consumption of market submarkets, with respect to key regions.

Who are the major driving forces expected to decide the fate of the industry worldwide.

To strategically profile the key players and comprehensively analyze their growth strategies.

What are the key barriers and threats believed to hinder the development of the industry?

To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

Who are the prominent market players making a mark in the market with their winning strategies?

To share detailed information about the key factors influencing the growth of the market

What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

Our Clients